Duke-NUS expands research capabilities with appointment of Professor Hendrik Luesch from UF

FHS
July 30, 2024
5:54 pm

Duke-NUS Medical School today announced the appointment of Professor Hendrik Luesch from the University of Florida (UF) as a joint faculty member.

Novo Nordisk’s ocedurenone Phase III flop costs company $816m

Novo Nordisk acquired ocedurenone in a $1.3bn deal in 2023. Image credit: oleschwander / Shutterstock. Novo Nordisk has said it will take a DKr5.7bn ($816m)

June 27, 2024

New WHO classification of kidney tumors integrates molecular diagnostics

Renal tumor pathology has evolved considerably, expanding from two main types of renal malignant tumors to over 20 distinct types.

June 18, 2024

Venture capital firm General Catalyst wants to buy a health system

Venture firms, convinced they’re jumpstarting the world’s most helpful tech products, have struggled mightily to get them in the hands of cash-strapped, risk-averse hospital administrators

October 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.